(MST) analysis were assessed in the least differentiated tumour section in each case. DNA flow cytometry was also performed.
Results-Quantitative pathological features differed significantly with respect to histological grade. The Ovarian cancer is the fifth most common type of cancer diagnosed in women in the Netherlands and Denmark, with age standardised incidence rates of 14-6 and 15-2, respectively.'2 The initial symptoms are usually non-specific and therefore most patients present with advanced disease.'
Despite recent improvements in treatment strategies for advanced ovarian malignancies, including optimal debulking surgery and cisplatin combination chemotherapy,6 clinical outcome is still fairly poor. Cisplatin has considerable side effects and a significant proportion of patients ultimately does not respond adequately to therapy. About 75% of these women will die of their disease; the median survival time is only two years. The total number of mitotic figures was counted in 25 contiguous fields of vision with a conventional light microscope (final magnification x 400, numerical aperture 0 75, field diameter 450 gm). Once focused, no further adjustment was permitted. The total number of clearly identifiable mitotic figures, fulfilling the criteria described previously,27 was counted and taken as the mitotic activity index (MAI).
The volume percentage of epithelium (VPE) was estimated (final magnification x 200, objective x 20) using a 42 point parallel Weibel grid, assuming that the tissue was isotropic, uniform and randomly oriented. At least 300 points covering epithelial or stromal cells were counted in each tumour section. The percentage of points overlying epithelial cells was taken as the VPE. Nuclear morphometric analysis was carried out using the PRODIT interactive digitising video overlay system (software version 5-1) (BMA, de Meem, The Netherlands). This system is composed of a video camera mounted on a microscope and linked to a video overlay board in a MS-DOS based computer. A final magnification on screen of approximately x 3000 (objective x 100) was used for assessing the mean nuclear area (MNA) and the volume weighted mean nuclear volume (iv). An automatic scanning stage is linked to the system, which permits electronic demarcation of the measurement area and the random systematic selection of fields of vision.28 To assess the MNA, the contours of 100 nuclei were traced using the mouse in 100 randomly selected fields of vision in each case. Thus, the mean (MNA) and standard deviation of the nuclear area (SDNA) were calculated in each case. The estimation ofthe vv was carried out as described elsewhere.29 33 Briefly, the intercepts of at least 90 nuclei in 14 fields of vision were measured. Thus, the intercepts were point sampled with a chance proportional to their volume. The unbiased estimate of vv was then obtained by raising the measured mean intercept lengths to the third power and multiplying by '/3.
Minimum spanning tree (MST) analysis was also performed using the PRODIT system. The final magnification displayed on the monitor was x 1900 (objective x 63). MST analysis was performed in 12 randomly selected fields of vision (each of which was 570 x 570 jim). In each field of vision the centres of gravity of all tumour cell nuclei present within the same epithelial layer were marked. These points were then automatically connected by the minimal total line length without forming loops, thus forming the MST. The variables obtained from the MST were the number of points, total line length, average line length, minimum line length, maximum line length, standard deviation of the line length, and percentage of points connected to one neighbouring nucleus, two neighbouring nuclei and three neighbouring nuclei. 34 The DNA index (DI) was calculated by dividing the channel numbers of the second and first Go/G, peak, being 10 in case of a single peak. Based on their DI, tumours were classified as diploid (DI=1-0), hyperdiploid (1 0<DI< 1 9), tetraploid (1 9 < DI < 2-1), and hypertetraploid (DI>2-1). In patients with FIGO stage III disease and with residual disease <2 cm in diameter (n = 67), the SDNA was selected first, followed by SD of line length (SDLL) of the MST. The point used (1 35) revealed that in the 35 patients with a low score long term survival was achieved in 57%, while in the group with a high score only 28% achieved long term survival (Mantel-Cox = 9 1, p = 0 003) (fig 2) .
In patients with FIGO stage III disease and with residual disease >2 cm in diameter (n = 67), the SDNA was selected first, followed by the percentage of points connected to three neighbouring nuclei (PCON3). The 
